![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF570 |
Gene summary for ZNF570 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF570 | Gene ID | 148268 |
Gene name | zinc finger protein 570 | |
Gene Alias | ZNF570 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | K7EP39 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
148268 | ZNF570 | HCC1_Meng | Human | Liver | HCC | 1.56e-02 | -3.62e-02 | 0.0246 |
148268 | ZNF570 | HCC1 | Human | Liver | HCC | 2.59e-07 | 1.98e+00 | 0.5336 |
148268 | ZNF570 | HCC2 | Human | Liver | HCC | 1.90e-32 | 3.11e+00 | 0.5341 |
148268 | ZNF570 | HCC5 | Human | Liver | HCC | 1.06e-19 | 2.12e+00 | 0.4932 |
148268 | ZNF570 | male-WTA | Human | Thyroid | PTC | 1.64e-04 | 5.55e-02 | 0.1037 |
148268 | ZNF570 | PTC01 | Human | Thyroid | PTC | 3.70e-02 | 9.69e-03 | 0.1899 |
148268 | ZNF570 | PTC06 | Human | Thyroid | PTC | 1.04e-05 | 1.10e-01 | 0.2057 |
148268 | ZNF570 | PTC07 | Human | Thyroid | PTC | 1.15e-03 | 6.11e-02 | 0.2044 |
148268 | ZNF570 | ATC13 | Human | Thyroid | ATC | 5.98e-58 | 8.70e-01 | 0.34 |
148268 | ZNF570 | ATC5 | Human | Thyroid | ATC | 4.67e-51 | 9.42e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | CRC | ![]() |
Stomach | GC | ![]() |
Stomach | CAG with IM | ![]() |
Stomach | CSG | ![]() |
Stomach | CAG | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF570 | SNV | Missense_Mutation | c.1147G>A | p.Glu383Lys | p.E383K | protein_coding | deleterious(0.02) | possibly_damaging(0.74) | TCGA-BH-A0W7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | ||
ZNF570 | SNV | Missense_Mutation | novel | c.934A>T | p.Ser312Cys | p.S312C | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-DS-A1OA-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | carboplatin | PD | |
ZNF570 | SNV | Missense_Mutation | novel | c.160G>A | p.Glu54Lys | p.E54K | protein_coding | tolerated(0.06) | benign(0.011) | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
ZNF570 | SNV | Missense_Mutation | c.1437N>G | p.Phe479Leu | p.F479L | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-IR-A3LI-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | ||
ZNF570 | insertion | In_Frame_Ins | novel | c.703_704insATTCTT | p.Thr235delinsAsnSerSer | p.T235delinsNSS | protein_coding | TCGA-DS-A1OD-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD | |||
ZNF570 | SNV | Missense_Mutation | c.1061G>A | p.Gly354Glu | p.G354E | protein_coding | deleterious(0.02) | probably_damaging(1) | TCGA-A6-3810-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
ZNF570 | SNV | Missense_Mutation | c.1511G>A | p.Gly504Glu | p.G504E | protein_coding | tolerated(0.12) | probably_damaging(1) | TCGA-AA-3833-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ZNF570 | SNV | Missense_Mutation | rs149552702 | c.774N>A | p.Asn258Lys | p.N258K | protein_coding | tolerated(0.25) | benign(0.007) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF570 | SNV | Missense_Mutation | c.881N>A | p.Arg294Lys | p.R294K | protein_coding | tolerated(0.05) | probably_damaging(0.991) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
ZNF570 | SNV | Missense_Mutation | c.1149N>T | p.Glu383Asp | p.E383D | protein_coding | deleterious(0) | possibly_damaging(0.908) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |